A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression

Clinical trial NCT07610473 · RECRUITING

Trial details

NCT number: NCT07610473
Sponsor: Draig Therapeutics Ltd
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Major Depressive Disorder (MDD)

Start date: 2026-05-14
Primary completion: 2027-05-01
Enrollment: 118

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.